D
Amplifon S.p.A. AMFPF
$11.21 -$0.80-6.66% OTC PK
Recommendation
Dividend Power Score
Prev Close
Volume
Avg Vol (90D)
--
Market Cap
Dividend & Yield
52-Week Range
P/E (TTM)
EPS (TTM)

Company Overview

Amplifon S.p.A. is a global provider of hearing care services and solutions, operating primarily in the healthcare services and medical devices retail industries. The company specializes in the distribution, fitting, and ongoing servicing of hearing aids and related auditory products, positioning itself as a leading specialty retailer rather than a manufacturer. Amplifon’s core revenue is driven by the sale of hearing aids, professional audiology services, and long-term customer care programs, primarily serving adults and elderly populations with hearing loss.

Founded in 1950 in Italy, Amplifon has evolved from a domestic distributor into one of the world’s largest hearing care retail networks. Its strategic positioning is based on scale, strong brand recognition, an extensive clinic network, and partnerships with leading hearing aid manufacturers. The company differentiates itself through standardized clinical protocols, omnichannel customer engagement, and a focus on recurring revenue from follow-up care and device replacement cycles.

Business Operations

Amplifon operates through geographically organized business segments that collectively manage thousands of retail hearing care centers. Its business is typically reported across EMEA, Americas, and Asia-Pacific regions, with each segment responsible for local operations, regulatory compliance, and market-specific growth initiatives. Revenue is generated primarily from hearing aid sales, professional fitting services, and post-sale care, with limited exposure to manufacturing risk due to its distributor-based model.

The company controls a broad portfolio of retail brands and operating subsidiaries, including GAES, Amplifon Hearing Health Care, and Amplifon Hearing Solutions, which enable localized branding and market penetration. Amplifon maintains strategic commercial relationships with major global hearing aid manufacturers, allowing it to offer a broad range of devices while remaining technologically independent. Operations are supported by centralized IT platforms, data analytics capabilities, and procurement scale.

Strategic Position & Investments

Amplifon’s strategy centers on organic network expansion, targeted acquisitions of independent hearing care clinics, and operational efficiency improvements. The company has historically pursued bolt-on acquisitions to consolidate fragmented local markets, most notably through the acquisition of GAES, which significantly strengthened its presence in Southern Europe and Latin America. Investments also focus on digital customer journeys, clinic modernization, and data-driven pricing and service optimization.

The company is actively involved in emerging areas such as tele-audiology, remote device tuning, and enhanced customer relationship management technologies. While Amplifon does not generally take minority stakes in unrelated businesses, it continues to invest in proprietary platforms and training systems that reinforce clinical quality and customer retention across its network.

Geographic Footprint

Amplifon is headquartered in Europe, with its corporate headquarters in Italy, and maintains a substantial operational presence across Western and Southern Europe, North America, Latin America, and Asia-Pacific. Europe remains its largest market by revenue, supported by strong positions in Italy, France, Spain, Germany, and other mature hearing care markets.

Internationally, the company has built scalable platforms in the United States, Australia, New Zealand, and select Asian markets, while also expanding in Latin America through established regional brands. Its geographic diversification reduces reliance on any single healthcare reimbursement system and provides exposure to long-term demographic trends associated with aging populations.

Leadership & Governance

Amplifon was founded by Algernon Charles Holland Sr., whose family remains a significant shareholder and strategic influence in the company. The company is led by an experienced executive team with long tenure in healthcare services, emphasizing disciplined capital allocation, ethical clinical standards, and sustainable growth.

Key members of leadership include:

  • Enrico VitaChief Executive Officer
  • Susan Carol HollandChair of the Board
  • Guido BardelliChief Financial Officer
  • Maarten ten HoorPresident EMEA
  • Chiara RivoliChief Human Resources Officer

The leadership philosophy emphasizes long-term value creation through scale advantages, professional excellence in audiology, and consistent governance practices aligned with public market expectations.

Data complied by narrative technology. May contain errors

Top Tech Stocks
See All »
B
NVDA NASDAQ $194.97
B
AAPL NASDAQ $281.74
B
AVGO NASDAQ $372.45
Top Consumer Staple Stocks
See All »
B
WMT NASDAQ $114.60
Top Financial Stocks
See All »
Top Energy Stocks
See All »
Top Health Care Stocks
See All »
B
LLY NYSE $1,229.93
B
JNJ NYSE $258.51
B
AMGN NASDAQ $360.55
Top Real Estate Stocks
See All »
B
PLD NYSE $138.89